Free Trial
NASDAQ:OM

Outset Medical (OM) Stock Price, News & Analysis

Outset Medical logo
$0.90 +0.04 (+4.65%)
(As of 11/13/2024 ET)

About Outset Medical Stock (NASDAQ:OM)

Key Stats

Today's Range
$0.80
$0.92
50-Day Range
$0.45
$0.86
52-Week Range
$0.44
$6.37
Volume
1.13 million shs
Average Volume
1.35 million shs
Market Capitalization
$47.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.70
Consensus Rating
Moderate Buy

Company Overview

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Outset Medical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
54th Percentile Overall Score

OM MarketRank™: 

Outset Medical scored higher than 54% of companies evaluated by MarketBeat, and ranked 569th out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Outset Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Outset Medical has received no research coverage in the past 90 days.

  • Read more about Outset Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Outset Medical are expected to grow in the coming year, from ($2.51) to ($1.95) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Outset Medical is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Outset Medical is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Outset Medical has a P/B Ratio of 0.99. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Outset Medical's valuation and earnings.
  • Percentage of Shares Shorted

    6.38% of the outstanding shares of Outset Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Outset Medical has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Outset Medical has recently decreased by 3.46%, indicating that investor sentiment is improving.
  • Dividend Yield

    Outset Medical does not currently pay a dividend.

  • Dividend Growth

    Outset Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.38% of the outstanding shares of Outset Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Outset Medical has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Outset Medical has recently decreased by 3.46%, indicating that investor sentiment is improving.
  • News Sentiment

    Outset Medical has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Outset Medical this week, compared to 5 articles on an average week.
  • Search Interest

    15 people have searched for OM on MarketBeat in the last 30 days. This is an increase of 275% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Outset Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $11,410.00 in company stock.

  • Percentage Held by Insiders

    Only 3.50% of the stock of Outset Medical is held by insiders.

  • Read more about Outset Medical's insider trading history.
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

OM Stock News Headlines

Why buying gold might be a mistake
Something strange just happened with gold. With the recent Fed rate cut… My charts are showing a breakout signal I haven't seen in years. But for now, I'm not rushing to buy gold. In fact, I'm telling everyone I know to hold off. Because I believe there’s a far better way to play this upcoming surge. It's a method that could turn a 1% gold price change into gains like 59%, 118%, or even 228%. And it doesn't involve buying a single ounce of physical gold or even buying any regular gold stock. I've been trading gold for nearly 20 years now and this is my #1 recommended approach for trading gold right now. Most traders miss them completely… But for those who know how to spot them, it takes their trades to a whole new level.
Outset Medical (OM) Gets a Buy from Stifel Nicolaus
Outset Medical Delivers Q3 Revenue Beat
See More Headlines

OM Stock Analysis - Frequently Asked Questions

Outset Medical's stock was trading at $5.41 at the start of the year. Since then, OM stock has decreased by 83.4% and is now trading at $0.90.
View the best growth stocks for 2024 here
.

Outset Medical, Inc. (NASDAQ:OM) released its quarterly earnings data on Thursday, October, 12th. The company reported ($0.71) earnings per share for the quarter, beating analysts' consensus estimates of ($0.74) by $0.03. Outset Medical had a negative trailing twelve-month return on equity of 164.92% and a negative net margin of 122.84%.

Outset Medical (OM) raised $175 million in an initial public offering (IPO) on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Outset Medical's top institutional investors include FMR LLC (9.09%), GSA Capital Partners LLP (2.13%), Assenagon Asset Management S.A. (0.76%) and Huntington National Bank (0.12%). Insiders that own company stock include Leslie Trigg, Steven S Williamson, Nabeel Ahmed, Jean-Olivier Racine, Marc Nash, John L Brottem, Martin Vazquez, Stacey L Porter and D Keith Grossman.
View institutional ownership trends
.

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Outset Medical investors own include Pinterest (PINS), Shopify (SHOP), Trade Desk (TTD), Fiverr International (FVRR), Teladoc Health (TDOC), Lemonade (LMND) and Block (SQ).

Company Calendar

Last Earnings
10/12/2023
Today
11/13/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/19/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Fax
N/A
Employees
520
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.70
High Stock Price Target
$6.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+448.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Net Income
$-172,800,000.00
Net Margins
-122.84%
Pretax Margin
-122.32%

Debt

Sales & Book Value

Annual Sales
$130.38 million
Book Value
$0.91 per share

Miscellaneous

Free Float
50,703,000
Market Cap
$45.05 million
Optionable
Not Optionable
Beta
1.95
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:OM) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners